Job description
As a Senior Research Scientist in DMPK at Elanco, you will be a subject matter expert in drug metabolism and pharmacokinetics, focusing on discovery and pre-clinical research projects. Your role will involve designing and implementing strategies that guide compound optimization and accelerate early R&D programs. You will collaborate with multidisciplinary teams and external partners to advance early pipeline packages. This position is integral to ensuring the success of drug development for both small and large molecule candidates.
Requirements
- Advanced scientific degree (PhD, PharmD, DVM, or Master's/Bachelor's degree with equivalent level of experience) in Pharmacology, Chemistry, Veterinary/Medical Sciences, or related scientific discipline.
- A minimum of 4 years of experience in pharmaceutical industry or academia in discovery and pre-clinical DMPK research.
- Demonstrated experience in both small and large molecule drug development.
- Strong foundational expertise in early-phase DMPK/ADME characterization and PK/PD data interpretation.
- Proficiency in PK software tools such as Phoenix WinNonlin, Monolix, or equivalent.
Responsibilities
- Serve as the PK/DMPK scientific lead across multidisciplinary discovery and pre-clinical research teams.
- Establish strategies to guide small and large molecule candidates toward nomination.
- Design, execute, and monitor in vitro DMPK/ADME and in vivo PK/PD profiling studies.
- Integrate DMPK findings with pharmacology and toxicology data to build robust lead profiles.
- Collaborate cross-functionally across global R&D and partner with external CROs and academic collaborators.
- Prepare and deliver clear scientific summaries, reports, and presentations on DMPK findings.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
